Cargando…

SMARCA2/BRM-Deficient Undifferentiated/Rhabdoid Carcinoma of Unknown Primary Site

Undifferentiated neoplasms of unknown primary sites are rare. It is difficult to identify their characteristics and determine the appropriate chemotherapy regimen to be used. Undifferentiated/rhabdoid carcinoma is reportedly associated with loss of SWI/SNF chromatin remodeling complexes, such as obs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tono, Yasutaka, Sukeno, Koushi, Tsunoda, Akira, Saito, Kanako, Yamashita, Yoshiki, Usui, Miki, Uchida, Katsunori, Imai, Hiroshi, Mizuno, Toshiro, Tawara, Isao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958621/ https://www.ncbi.nlm.nih.gov/pubmed/35431870 http://dx.doi.org/10.1159/000521632

Ejemplares similares

Atezolizumab-Induced Sarcoidosis-Like Reaction in a Patient with Metastatic Breast Cancer
por: Tsunoda, Akira, et al.
Publicado: (2022)

The silencing of the SWI/SNF subunit and anticancer gene BRM in Rhabdoid tumors
por: Kahali, Bhaskar, et al.
Publicado: (2014)

Thoracic SMARCA4-deficient undifferentiated tumor
por: Jiang, Jiapeng, et al.
Publicado: (2023)

Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type
por: Karnezis, Anthony N, et al.
Publicado: (2015)

Pertuzumab, trastuzumab and eribulin mesylate therapy for previously treated advanced HER2-positive breast cancer: a feasibility study with analysis of biomarkers
por: Tono, Yasutaka, et al.
Publicado: (2018)

Induction of functional Brm protein from Brm knockout mice
por: Thompson, Kenneth W., et al.
Publicado: (2015)

Case Series of SMARCA4-Deficient Undifferentiated Esophageal Carcinoma
por: Ahmed, Omar T, et al.
Publicado: (2022)

Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma
por: Schallenberg, Simon, et al.
Publicado: (2020)

A Rare Case of Undifferentiated Rhabdoid Carcinoma of the Colon
por: Nasir, Syed Alishan, et al.
Publicado: (2022)

SMARCA4-deficient undifferentiated thoracic tumor: A case report
por: Kwon, Hee Jung, et al.
Publicado: (2023)

A dramatic course after the resection of an SMARCA4‐deficient undifferentiated tumour
por: Iguchi, Takafumi, et al.
Publicado: (2022)

Pathological characteristics and immune microenvironment of SMARCA4-deficient undifferentiated uterine sarcoma
por: Gao, Jie, et al.
Publicado: (2023)

A case of radio-insensitive SMARCA4-deficient thoracic undifferentiated carcinoma with severe right heart failure
por: Ito, Shotaro, et al.
Publicado: (2021)

Undifferentiated colonic neoplasm with SMARCA4 germline gene mutation and loss of SMARCA4 protein expression: a case report and literature review
por: Duan, Huanli, et al.
Publicado: (2021)

Notable Response of SMARCA4-Deficient Undifferentiated Uterine Sarcoma to Palliative Radiation Therapy
por: Kurokawa, Mariko, et al.
Publicado: (2021)

SMARCA4-Deficient Undifferentiated Tumor: A Rare Malignancy With Distinct Clinicopathological Characteristics
por: Al-Shbool, Ghassan, et al.
Publicado: (2022)

Thoracic SMARCA4-deficient undifferentiated tumor—a case of an aggressive neoplasm—case report
por: Roden, Anja C.
Publicado: (2021)

Case Report: SMARCA4 (BRG1)-deficient undifferentiated carcinoma of gallbladder with genetic analysis
por: Meng, Xiangpeng, et al.
Publicado: (2023)

Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases
por: Holdhof, Dörthe, et al.
Publicado: (2020)

A case of thoracic SMARCA4‐Deficient undifferentiated tumor successfully treated with combination Ipilimumab–Nivolumab
por: Nakano, Yoshio, et al.
Publicado: (2022)

Thoracic SMARCA4‐deficient undifferentiated tumor diagnosed by transbronchial mediastinal cryobiopsy: A case report
por: Takemura, Chihiro, et al.
Publicado: (2023)

Thoracic SMARCA4‐deficient undifferentiated tumour: Diagnostic challenges and potential for misdiagnosis in small tissue samples
por: Maartens, Deborah Johanna, et al.
Publicado: (2023)

Promising efficacy of immune checkpoint inhibitor plus chemotherapy for thoracic SMARCA4-deficient undifferentiated tumor
por: Lin, Ying, et al.
Publicado: (2023)

BRG1 and BRM loss selectively impacts RB and P53, respectively: BRG1 and BRM have differential functions in vivo
por: Marquez-Vilendrer, Stefanie B., et al.
Publicado: (2016)

SMARCA4‐deficient undifferentiated tumor that responded to chemotherapy in combination with immune checkpoint inhibitors: A case report
por: Utsumi, Takahiro, et al.
Publicado: (2022)

Diagnosis of a SMARCA4 ‐deficient undifferentiated tumor using multigene panel testing: A case report
por: Marumo, Yoshiaki, et al.
Publicado: (2023)

Association of BRM promoter polymorphisms and esophageal adenocarcinoma outcome
por: Korpanty, Grzegorz J., et al.
Publicado: (2017)

A Rare Case of Undifferentiated Carcinoma of the Colon with Rhabdoid Features: A Case Report and Review of the Literature
por: Moussaly, E., et al.
Publicado: (2015)

Immune-Desert Tumor Microenvironment in Thoracic SMARCA4-Deficient Undifferentiated Tumors with Limited Efficacy of Immune Checkpoint Inhibitors
por: Gantzer, Justine, et al.
Publicado: (2022)

Case report: A rapid response to immunotherapy in a thoracic SMARCA4-deficient undifferentiated tumor with respiratory failure
por: Shi, Liyong, et al.
Publicado: (2022)

Small Cell Carcinoma of Ovary, Hypercalcemic Type (Malignant Rhabdoid Tumor of Ovary) with Loss of SMARCA4 (BRG1) Expression: Report of Two Cases
por: Sahay, Ayushi, et al.
Publicado: (2020)

Thoracic SMARCA4-Deficient Undifferentiated Tumor With ALK Fusion Treated With Alectinib Achieved Remarkable Tumor Regression: Case Report
por: Sheng, Jin, et al.
Publicado: (2023)

Effectiveness of tislelizumab when combined with etoposide and carboplatin in patients with SMARCA4-deficient undifferentiated thoracic tumor: a case report
por: Yang, Pan, et al.
Publicado: (2023)

Combined use of pathological and genomic alteration analyses for the diagnosis of gray zone lymphoma
por: Nishimura, Komei, et al.
Publicado: (2022)

Analysis of SMARCA4 and SMARCA2 Loss in Lung Sarcomatoid Carcinomas
por: Urer, Halide Nur, et al.
Publicado: (2023)

Tumor Mesenchymal Stromal Cells Regulate Cell Migration of Atypical Teratoid Rhabdoid Tumor through Exosome-Mediated miR155/SMARCA4 Pathway
por: Yang, Yi-Ping, et al.
Publicado: (2019)

Antagonistic Roles for BRM and BRG1 SWI/SNF Complexes in Differentiation
por: Flowers, Stephen, et al.
Publicado: (2009)

The complete genome sequence of the rumen methanogen Methanobacterium formicicum BRM9
por: Kelly, William J, et al.
Publicado: (2014)

Evolutionary Conservation of Structural and Functional Coupling between the BRM AT-Hook and Bromodomain
por: Lupo, Brianna E., et al.
Publicado: (2021)

SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas
por: Rekhtman, Natasha, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ms9od0nf518v75fr5brd1d51ba